| ORIGINAL ARTICLE |
|
| Year : 2003 | Volume
: 69
| Issue : 1 | Page : 25--26 |
Treatment of schamberg's disease with pentoxifylline - therapeutic trial
V Gandhi, A Singal, B Sachdeva, SN Bhattacharya
Department of Dermatology and STD UCMS & GTB Hospital, Shahdara, Delhi - 110 095, India
Correspondence Address:
V Gandhi
Department of Dermatology and STD UCMS & GTB Hospital, Shahdara, Delhi - 110 095
India
PMID: 17642818
Twenty patients with Schamberg's disease were started on pentoxifylline (400 mg once daily) for a period of 8 weeks. Improvement was assessed at 2 weekly intervals by two observers independently and graded as mild (<25%, moderate (25-50%) and marked (>50%). Marked improvement was observed in 10/20(50%) patients. We conclude that pentoxifylline should be considered as first line therapy in all patients with Schamberg's disease
[FULL TEXT] [PDF Not available]*
|
